Quality of life in users and non-users of hormone replacement therapy;Qualidade de vida em usuárias e não usuárias de terapia de reposição hormonal

Revista da Associacao Medica Brasileira

Volumn 51, Issue 3, 2005, Pages 133-138

  Zahar, Sílvia E V ^b   Aldrighi, José M ^a   Pinto Neto, Aarão M ^b   Conde, Délio M ^b   Zahar, Luiz O ^b   Russomano, Fábio ^b  

^a NONE   (Brazil)

^b NONE

Author keywords

Hormone replacement therapy; Kupperman index; Menopause; Quality of life; SF 36 questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; MIDDLE AGED; NONPARAMETRIC TEST; POSTMENOPAUSE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SOCIOECONOMICS;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POSTMENOPAUSE; QUALITY OF LIFE; SOCIOECONOMIC FACTORS; STATISTICS, NONPARAMETRIC;

EID: 33644876844     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302005000300012     Document Type: Article

References (33)

1. World Health Organization. Research on the menopause. Geneve, WHO Technical Report Series, 1981.
2. World Health Organization. Research on the menopause in the 1990s. Report of a WHO Scientific group. WHO Technical Report Series no 866, 1996.3.
3. Pedro AO, Pinto-Neto AM, Costa-Paiva LHS, Osis MJ, Hardy E. Idade de ocorrência da menopausa natural em mulheres brasileiras: resultados de um inquérito populacional domiciliar. Cad Saúde Pública 2003; 19: 17-25.
4. Datasus: banco de dados. [on line] 2003. Disponível em: http://www.datasus.gov.br
5. Dennerstein L. Depression in the menopause. Obstet and Gynaecol Clin N Am 1987; 4:33-49.
6. Aldrighi JM, Bueno JGR. Climatério: manifestações clínicas. Ars Cvrandi 1995; 1 (Especial): 22-4.
7. Genazzani AR. Controversial issues in climacteric medicine: cardiovascular disease and hormone replacement therapy. Maturitas 2001;38:263-71.
8. Dennerstein L, Smith A, Morse C, Burger H, Green A, Hopper J, Ryan M. Menopausal symptoms in Australian women. Med J Austral 1993;159:232-236.
9. McKinlay S, Jefferys M. The menopausal syndrome. Brit J Prevent Soc Med 1974; 28:108-115.
10. Speroff L, Glass RH, Kase NG. Menopause and postmenopausal hormone therapy. In Clinical Gynecologic endocrinology and Infertility. 5 ed Baltimore, Williams & Wilkins, 1994. p.583-649.
11. The North American Menopause Society (NAMS). Achieving long-term of menopausal ERT/HRT: consensus opinion of the North American Menopause Society. Menopause 1998;2:69-76.
12. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993;168:824-30.
13. Hilditch JR, Lewis J, Ross AH, Peter A, van Maris B, Franssen E, et al. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with and oral progestin on quality of life in postmenopausal women. Maturitas 1996; 24:177-84.
14. Paganini-Hill A, Henderson V. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-61.
15. Gelfand MM, Moreau M, Ayotte NJ, Hilditch JR, Wong BA, Lau CY. Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study. Menopause 2003; 10:29-36.
16. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003; 348:1839-54.
17. Wilson DH, Taylor AW, Maclennan AH. Health status of hormone replacement therapy users and non-users as determined by the SF-36 quality of life dimension. Climacteric 1998;1:50-4.
18. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneve, WHO, Technical Reports Series no 843, 1994.
19. Conselho Nacional de Saúde, 1996. Resolução no 196/96. Informe Epidemiológico do SUS, no 2, Brasília.
20. Kupperman HS, Blatt MHG, Wiesbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol 1953;13:688-703.
21. Ware, JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
22. Wood-Dauphinee S. Assessing quality of life in clinical research: from where have we come and where are we going. J Clin Epidemiol 1999;52:355-63.
23. Ciconelli RM. Tradução para o português e validação do questionário genérico de avaliação da qualidade de vida "Medical Outcomes Study 36-item Short-Form Health Survey (SF-36)" [tese]. São Paulo: Universidade Federal de São Paulo, 1997.
24. Pedro AO, Pinto-Neto AM, Costa-Paiva L, Osis MJ, Hardy E. Procura de serviço médico por mulheres climatéricas brasileiras. Rev Saúde Pública 2002; 36:484-90.
25. Dennerstein L, Burrows GD, Hyman GJ, Sharpe K. Hormone Therapy and affect. Maturitas 1979;1:247-59.
26. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-5.
27. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-43.
28. Marsh MS, Whitehead MI. Management of the menopause. Br Med Bull 1992; 48:426-57.
29. Abraham S, Llewellyn-Jones D, Perz J. Changes in Australian women's perception of the menopause and menopausal symptoms before and after the climacteric. Maturitas 1995;20:121-8.
30. Polo-Kantola P, Erkkola R, Helenius H. When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol 1998;5:1002-9.
31. Pedro AO. Inquérito populacional domiciliar sobre o climatério e a menopausa em mulheres do município de Campinas [tese]. Campinas: Faculdade de Ciências Médicas, Universidade Estadual de Campinas; 1999.
32. Girdler SS, O'Briant C, Steege J, Grewen K, Light KC. A comparison of the effect of estrogen with or without progesterone on mood and physical symptoms in postmenopausal women. J Womens Health Gend Based Med 1999;8:637-46.
33. O'dea I, Hunter MS, Anjos S. Life satisfaction and health-related quality of life (SF-36) of middle-aged men and women. Climacteric 1999;2:131-40.